Lantus Solostar Sanofi pen, 5x300IU (INT)
$96.00
Brand: Sanofi
Raw material: Insulin
Package: 5 x 300iu
Stock: International
Technical Analysis of Basal Nutrient Partitioning
In the field of metabolic research, Lantus Solostar is a long-acting recombinant human insulin analog. Unlike rapid-acting variants, it is designed to provide a steady, background level of insulin that mimics the natural basal secretion of a healthy pancreas. At globalanabolicsteroids.com, we analyze this compound for its ability to maintain a constant anabolic state without the dangerous blood sugar crashes associated with shorter esters.
Molecular Architecture and 2025 Release Dynamics
The unique pharmacokinetics of Lantus Solostar are a result of specific amino acid substitutions that alter its isoelectric point:
-
Acidic Solubility: The solution is formulated at a pH of 4.0. Upon subcutaneous injection, the neutral pH of the body causes the insulin to form microprecipitates.
-
Timed Release: These microprecipitates dissolve slowly over 24 hours, providing a constant, peakless concentration of insulin in the bloodstream.
-
Structural Modification: It differs from human insulin by the replacement of asparagine with glycine at position A21 and the addition of two arginines at the B-chain terminus ($C_{267}H_{404}N_{72}O_{78}S_{6}$).
Technical Specifications
For laboratory documentation and metabolic modeling, the following data defines the compound:
| Property | Scientific Detail |
| Active Substance | Insulin Glargine (rDNA origin) |
| Delivery System | SoloStar Prefilled Pen (3mL) |
| Concentration | 100 Units/mL (U-100) |
| Onset of Action | ~1.5 – 2 Hours |
| Active Duration | ~24 Hours (Peakless) |
Core Research Mechanisms in 2025
This analog is utilized in advanced protocols to observe the optimization of recovery and growth:
-
Glucose Disposal and Glycogen Satiety:
Researchers use Lantus Solostar to study the “shuttling” of carbohydrates into skeletal muscle. By maintaining basal levels, it ensures that muscle glycogen stores are constantly replenished, even during fasting periods.
-
Mitigation of GH-Induced Resistance:
High-dose Growth Hormone research often leads to elevated fasting blood glucose. This basal insulin acts as a metabolic buffer, preserving insulin sensitivity and protecting pancreatic beta cells from exhaustion.
-
Inhibition of Proteolysis:
A primary research goal in 2025 is the suppression of muscle protein breakdown. Lantus Solostar provides a non-stop anti-catabolic signal, making it a critical component in “Mass Stack” protocols where tissue preservation is paramount.
Laboratory Handling and Safety
-
Precision Dosing: The SoloStar pen allows for 1-unit increments, which is vital for maintaining tight control in research subjects.
-
Hypoglycemia Risk: While peakless, an overdose can lead to prolonged hypoglycemia. Continuous glucose monitoring (CGM) is a 2025 standard for these studies.
-
Stability: Once in use, the pen can be kept at room temperature (below 30°C) for up to 28 days.
Quality Commitment at GlobalAnabolicSteroids.com
Integrity in metabolic research depends on pharmaceutical-grade precision. At globalanabolicsteroids.com, we ensure that every profile for Lantus Solostar is backed by 2025 clinical data and cold-chain transparency. We provide the essential technical data required for high-impact studies into the future of metabolic synergy.
Benefits
-
- Increased Muscle Mass: Supports significant gains in muscle size and strength.
Additionally, PT-141 has been shown to support various physiological enhancements during studies.
- Improved Performance: Enhances endurance and reduces recovery times during workouts.
- Stable Hormone Levels: Helps maintain consistent testosterone levels in the body.
Dosage and Administration
-
- Typical Dosage: Commonly administered in doses ranging from 375 mg to 750 mg per week, tailored to individual goals and experience levels.
- Administration: Injected intramuscularly, usually once a week.
Researchers often note the effectiveness of PT-141 in various testing conditions.
Potential Side Effects
- Estrogenic Effects: Risk of water retention, gynecomastia, and mood swings.
- Androgenic Effects: Possible side effects include acne, hair loss, and increased aggression.SStanozolol
- Cardiovascular Risks: Long-term use can lead to elevated blood pressure and cholesterol levels.
Considerations
-
- Consultation Required: It’s important to consult a healthcare professional before use, especially for those with existing health conditions.
Understanding the use of PT-141 is vital for well-informed research practices.
- Legal Compliance: Ensure adherence to local laws regarding the purchase and use of anabolic steroids.
| Brand |
Sanofi |
|---|---|
| SHIPPING LOCATIONS |
INTERNATIONAL SHIPPING |

Reviews
There are no reviews yet.